OFLOXACIN — all Canadian products
14 DINs
1 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is OFLOXACIN, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02143291 | OCUFLOX | ABBVIE CORPORATION | Solution | Ophthalmic | OFLOXACIN 0.3 % | Marketed | |
| 02248398 | APO-OFLOXACIN | APOTEX INC | Solution | Ophthalmic | OFLOXACIN 0.3 % | Cancelled Post Market | |
| 02049414 | FLOXIN I.V. LIQ 20MG/ML | ORTHO PHARMACEUTICAL, DIVISION OF JANSSEN-ORTHO INC. | Liquid | Intravenous | OFLOXACIN 20 MG | Cancelled Pre Market | |
| 01968424 | FLOXIN TABLETS 200MG | JANSSEN INC | Tablet | Oral | OFLOXACIN 200 MG | Cancelled Post Market | |
| 01968416 | FLOXIN TABLETS 300MG | JANSSEN INC | Tablet | Oral | OFLOXACIN 300 MG | Cancelled Post Market | |
| 01968408 | FLOXIN TABLETS 400MG | JANSSEN INC | Tablet | Oral | OFLOXACIN 400 MG | Cancelled Post Market | |
| 02243475 | NOVO-OFLOXACIN | NOVOPHARM LIMITED | Tablet | Oral | OFLOXACIN 300 MG | Cancelled Post Market | |
| 02243476 | NOVO-OFLOXACIN | NOVOPHARM LIMITED | Tablet | Oral | OFLOXACIN 400 MG | Cancelled Post Market | |
| 02243474 | NOVO-OFLOXACIN | NOVOPHARM LIMITED | Tablet | Oral | OFLOXACIN 200 MG | Cancelled Post Market | |
| 02231532 | OFLOXACIN TABLETS | AA PHARMA INC | Tablet | Oral | OFLOXACIN 400 MG | Cancelled Post Market | |
| 02231529 | OFLOXACIN TABLETS | AA PHARMA INC | Tablet | Oral | OFLOXACIN 200 MG | Cancelled Post Market | |
| 02231531 | OFLOXACIN TABLETS | AA PHARMA INC | Tablet | Oral | OFLOXACIN 300 MG | Cancelled Post Market | |
| 02252570 | PMS-OFLOXACIN | PHARMASCIENCE INC | Solution | Ophthalmic | OFLOXACIN 0.3 % | Cancelled Post Market | |
| 02247189 | SANDOZ OFLOXACIN | SANDOZ CANADA INCORPORATED | Solution | Ophthalmic | OFLOXACIN 0.3 % | Cancelled Post Market |
Browse other molecules: